Title : Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.

Pub. Date : 2020 Mar

PMID : 31812754






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Longitudinal evaluation of mutations in blood samples was a pre-specified secondary objective in the BELIEF trial of erlotinib/bevacizumab in advanced EGFR-positive NSCLC. erlotinib epidermal growth factor receptor Homo sapiens